A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53433

language	eng
Author	Miura Katsuhiro Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan Konishi Jun Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan Miyake Takaaki Department of Oncology/Hematology, Shimane University Hospital, Shimane, Japan Makita Masanori Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan Hojo Atsuko Division of Hematology and Oncology, Kasukabe Medical Center, Saitama, Japan Masaki Yasufumi Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan Uno Masatoshi Division of Internal Medicine, Kaneda Hospital, Okayama, Japan Ozaki Jun Department of Hematology, Toyama Prefectural Central Hospital, Toyama, Japan Yoshida Chikamasa Department of Hematology, National Hospital Organization Minami-Okayama Medical Center, Okayama, Japan Niiya Daigo Department of Hematology, Okayama Rosai Hospital, Okayama, Japan Kitazume Koichi Department of Hematology, Showa General Hospital, Tokyo, Japan Maeda Yoshinobu Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan Takizawa Jun Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan Sakai Rika Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan Yano Tomofumi Department of Hematology, Okayama Rosai Hospital, Okayama, Japan Yamamoto Kazuhiko Department of Hematology, Okayama City Hospital, Okayama, Japan Sunami Kazutaka Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan Hiramatsu Yasushi Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Hyogo, Japan Aoyama Kazutoshi Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan Tsujimura Hideki Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan Murakami Jun The Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan Hatta Yoshihiro Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan Kanno Masatoshi Oncology Center, Nara Medical University Hospital, Nara, Japan
Subject	Comorbidity; Diffuse large B-cell lymphoma; Geriatric assessment; Hypoalbuminemia; Personalized medicine; R-CHOP chemotherapy
Journal Title	ONCOLOGIST
Volume	22
Issue	5
Start Page	554
End Page	560
ISSN	1083-7159
ISSN（Online）	1549-490X
Published Date	2017
DOI	10.1634/theoncologist.2016-0260
PubMed ID	28408622
Publisher	WILEY
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	Katsuhiro Miura: Chugai, Kyowa Hakko Kirin (H); Takaaki Miyake: Chugai (H); Atsuko Hojo: Chugai, Kyowa Hakko Kirin (H); Yasufumi Masaki: Shionogi (H), Chugai, Kyowa Hakko Kirin (H, RF); Jun Takizawa: Chugai, Kyowa Hakko Kirin (H); Rika Sakai: Chugai, Kyowa Hakko Kirin (H, RF), Nippon Kayaku (RF); Kazutaka Sunami: Celgene (H, RF), Ono, Takeda, Daiichi Sankyo, Novartis, Sanofi, Janssen, Bristol- Myers Squibb (RF); Kazutoshi Aoyama: Kyowa Hakko Kirin (H); Yoshihiro Hatta: Chugai, Kyowa Hakko Kirin (H); Masatoshi Kanno: Chugai (H), Nippon Kayaku (H, RF). The other authors indicated no financial relationships.